Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
113,698,300
-
Share change
-
+6,601,042
-
Total reported value
-
$5,607,833,542
-
Put/Call ratio
-
44%
-
Price per share
-
$49.38
-
Number of holders
-
248
-
Value change
-
+$347,656,563
-
Number of buys
-
162
-
Number of sells
-
94
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q2 2017
As of 30 Jun 2017,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
248 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,698,300 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, Aristotle Capital Management, LLC, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, BAIN CAPITAL INVESTORS LLC, and FMR LLC.
This page lists
248
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.